SCHEMBL15944225

SCHEMBL15944225

C=C1COC(C)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20117452 1.00
SCHEMBL12959755 0.74
SCHEMBL19157040 0.74
SCHEMBL15171168 0.71
SCHEMBL13540239 0.71
SCHEMBL12406689 0.71
SCHEMBL19271674 0.71
SCHEMBL18756577 0.70
SCHEMBL22295939 0.67
SCHEMBL18083691 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3689881-A1 MACROCYCLIZATION REACTIONS AND INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANALOGS OF HALICHONDRIN B Eisai R&D Management Co., Ltd. (JP) 2020-08-05 EP disclosed
CN-106574020-B Copolymer and formed body 株式会社可乐丽 2019-03-19 CN disclosed
CN-104995223-B Copolymer and formed body 株式会社可乐丽 2017-09-08 CN disclosed
US-8975300-B2 Ketone compounds and compositions for cholesterol management and related uses ESPERION THERAPEUTICS, INC. (US) 2015-03-10 US disclosed
US-20140228439-A1 KETONE COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES ESPERION THERAPEUTICS, INC. (US) 2014-08-14 US disclosed